Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection

NCT07028970 · clinicaltrials.gov ↗

RECRUITING

Status

1500

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

OTHER: No Intervention (subjects were previously treated with Equecabtagene Autoleucel Injection) )

Sponsor

Nanjing IASO Biotechnology Co., Ltd.